P rez-Montero, HM, Lin, Y, Mera, MA, Guedea, F, Navarro, A. Could radiotherapy be avoided in poor prognosis spinal cord compression?. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Tejedor, N, Montezuma, L, Vivancos, H, Jornet, N, P rez-Alija, J, Gallego, P, Ans n, C, Ruiz, A, Barcel , M, Fuentes, MJ, Leo, F, Dom nguez, A, Riu, V, Carrasco, P, Sancho, G, Majercakova, K. Dosimetric impact of individual fraction vs first fraction optimization in vaginal HDR brachytherapy. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Bonet, M, Recalde, E, Soto-Cambres, AM, Martinez, A, Murcia, M, Nu ez, M, Mases, J, Yufera, JC, Alvarez, A, Feltes, N, Hernandez, L, Ramos, L, Garcia, V. Use of Social Media in Radiation Oncology: Multicenter Data from the GOCO Group. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Herv s, A, Zapatero, A, Carballo, AM, Rodr guez, A, Barrado, M, Salinas, A, Eito, C, Pe as, M, L pez-Campos, F, Cou ago, F, de Vidales, CM, Otero, A, Samper, P, Peleteiro, P, Depiaggio, MS, Guerrero, L, Porras, M, Lozano, AJ, P rez, R, Rodr guez-Melc n, I, Caballero, B, Vasquez, WA, Alv rez, A, Sancho, G, L zaro, J. Phase II trial of hypofractionated postoperative radiotherapy in prostate cancer: NCT04484038. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Errasti, AM, Soto-Cambres, AM, Mitre, SJR, Ni o, LM, Calvet, G, Perez-Montero, H, Pardo, GS. Impact of dose escalation on positive nodes in prostate cancer patients with pelvic nodal disease. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Najjari-Jamal, D, Cordoba-Largo, S, Rovirosa, A, Sanchez-Belda, M, Majercakova, K, Garcia-Cabezas, S, Gimeno-Morales, M, Guevara-Barrera, D, Mu oz, T, De La Fuente, C, Mico, S, Matute, R. IS REIRRADIATION IN GYNAECOLOGICAL CANCER A REALITY? : A NATIONAL (SPANISH) SURVEY. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Ans n, C, Carrasco, P, Bermejo, S, Jimenez, J, Ventosa, N, Balart, J, Jornet, N, Gallego, P, P rez-Alija, J, Tejedor, N, Vivancos, H, Ruiz, A, Barcel , M, Leo, F, Dom nguez, A, Riu, V, Sancho, G. EBH abdominal SBRT: inter- and intrafraction motion using two commercial monitoring systems. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Bermejo, S, Ans n, C, Carrasco, P, Jim nez, J, Ventosa, N, de Segura, GG, Balart, J, Otero, E, Vizuete, A, Domenech, J, Suri ach, F, Soto, A, Farr , N, Jornet, N, Sancho, G. Impact of coaching reinforcement on SGRT-guided abdominal SBRT with expiration breath-hold (EBH). RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Montezuma, L, Leon-Vintr , X, Majerc kov , K, Juli , J, Farr , N, Rojas, J, Rabi, S, Crespo, S, Calvet, G, Camacho, M, Sancho, G. Prognostic ability of TGF-ß and IL-6 in patients with HNSCC treated with RT. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Pla, EO, Cambres, AMS, Franco, PG, Sala, NJ, Rabi, S, P rez, SMC, Molinas, GC, Beltr n, JS, Recio, SM, Mart nez, SB, Pardo, GS, Bernad , NF. Clinical and dosimetric predictors of cardiotoxicity for locally advanced lung cancer. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Pla, EO, Garc a, AJ, L pez, LR, Sanahuja, JCJ, Rabi, S, Molinas, GC, P rez, SMC, L pez-Bravo, DP, Manrique, ACV, Cullell, BM, Rodr guez, JB, S nchez, MCM, Pardo, GS, Serra, JB. Treatment of rectal cancer in elderly patients >80 years might not be limited by their age. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Puente, J, Arrea, FA, Rueda, OB, Gauna, DC, Durán, I, Avila, JJF, Gómez-Iturriaga, A, Blázquez, MJP, Fentes, DP, Pardo, GS, Casas, JAV, Gratal, P, Pardo, MT, Porta, VG. Criteria and indicators to evaluate quality of care in genitourinary tumour boards. Clinical & Translational Oncology. 2024; 26(7)DOI:10.1007/s12094-024-03381-z. PMID:38341809. IF:2.500(Q3/6D).

Cacho, D, Congregado, B, Belenchon, IR, Espinos, EL, Basterretxea, L, Sancho, G, Lainez, N, Buchser, D, Sanguedolce, F, Gurruchaga, I, Mediavilla, BG, Esteban, B, Hernandez, A, Lashey, M, Duran, I. PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(4_SUPPL)DOI:10.1200/JCO.2024.42.4_suppl.114. PMID:. IF:41.900(Q1/1D).

Puente, J, Arrea, FA, Buisán, O, Castellano, D, Duran, I, Avila, JJF, Gómez-Iturriaga, A, Blázquez, MJP, Fentes, DP, Sancho, G, Casas, JAV, Gratal, P, Pardo, MT, Guillem, V. Criteria and indicators to evaluate quality of care in genitourinary tumor boards.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(4_SUPPL)DOI:10.1200/JCO.2024.42.4_suppl.388. PMID:. IF:41.900(Q1/1D).

Martinez-Recio, S, Barba, A, Farré, N, Majem, M. Oligometastatic disease: a need for consensus to cure the incurable in a multidisciplinary approach. Chinese Clinical Oncology. 2024; 13(2)DOI:10.21037/cco-23-118. PMID:38199796. IF:(Q/D).

Bonet, M, Recalde, E, Soto, A, Martinez, A, Murcia, M, Mases, J, Fernandez, MN, Yufera, JC, Alvarez, A, Eraso, MA, Feltes, N, Hernandez, L, Bernard, P, Ramos, L, Garcia, V. Use of social media in radiation oncology: multicenter data from the GOCO Group. Reports Of Practical Oncology And Radiotherapy. 2024; 29(2)DOI:10.5603/rpor.100386. PMID:39143971. IF:(Q/D).

Oladeru, OT, Dunn, SA, Li, J, Coles, CE, Yamauchi, C, Chang, JS, Cheng, SHC, Kaidar-Person, O, Meattini, I, Ramiah, D, Kirby, A, Hijal, T, Marta, GN, Poortmans, P, Isern-Verdum, J, Zissiadis, Y, Offersen, BV, Refaat, T, Elsayad, K, Hijazi, H, Dengina, N, Belkacemi, Y, Luo, FD, Lu, S, Griffin, C, Collins, M, Ryan, P, Larios, D, Warren, LE, Punglia, RS, Wong, JS, Spiegel, DY, Jagsi, R, Taghian, A, Bellon, JR, Ho, AY. Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic. Jco Global Oncology. 2023; 9DOI:10.1200/GO.23.00010. PMID:37471670. IF:(Q/D).

Lococo F., Boldrini L., Diepriye, CD, Evangelista J., Nero C., Flamini S., Minucci A., De Paolis E., Vita E., Cesario A., Annunziata S., Calcagni M.L., Chiappetta M., Cancellieri A., Larici A.R., Cicchetti G., Troost, EGC, Róza Á., Farré N., Ozturk, E, Van Doorne D., Leoncini F., Urbani A., Trisolini R., Bria E., Giordano A., Rindi G., Sala E., Tortora G., Valentini V., Boccia S., Margaritora S., Scambia G.. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study. BMC CANCER. 2023; 23(1)DOI:10.1186/s12885-023-10997-x. PMID:37312079. IF:3.400(Q2/4D).

León X., Farré N., Montezuma L., Holgado A., Vásquez R., Neumann E., Quer M.. Results of radiotherapy in oropharyngeal carcinomas. Acta Otorrinolaringologica Espanola. 2023; 74(3)DOI:10.1016/j.otorri.2022.04.002. PMID:37149134. IF:(Q/D).

Moreno-Acosta, P, Gamboa, O, Gonzalez-Prieto, C, Romero-Rojas, A, Serra, JB, Diaz, GD, Malaver, G, Bouleftour, W, Magne, N. hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer. RADIATION RESEARCH. 2023; 199(5)DOI:10.1667/RADE-22-00121.1. PMID:36888727. IF:2.500(Q2/4D).